Joint Research Centre of the European Commission
As the science and knowledge service of the European Commission, the Joint Research Centre provides independent, evidence-based knowledge and science, supporting EU policies to positively impact society.
dealiiX
"dealii-X: an Exascale Framework for Digital Twins of the Human Body" is a project funded by the European Union that aims to develop a scalable, high-performance computational platform to create accurate digital twins of human organs using the deal.II finite element library.
EBRAINS RI
EBRAINS is an open research infrastructure (RI) that provides data, tools and services for brain-related research – from the molecular and cellular levels to the whole organ. The EBRAINS infrastructure was originally built by the EU-funded Human Brain Project and is now advancing with the support of the European Commission, a network of National Nodes and institutional partners from across Europe.
ReBone
ReBone is part of the Marie Skłodowska-Curie Doctoral Network. Its full project title is: End-to-end multidisciplinary optimal design for improved personalized bioactive glass/ceramic bone substitute implants – ReBone
SANO
Sano Centre for Computational Medicine is an international research institute advancing computational medicine and digital transformation of healthcare. Our mission is to enable data-driven health decisions. Founded in 2019, Sano is based in Kraków, Poland and holds the status of a Teaming for Excellence Centre awarded by the European Commission.
SMASH-HCM
SMASH-HCM, an initiative focused on transforming the landscape of Hypertrophic Cardiomyopathy (HCM). Our project aims to develop a cutting-edge digital-twin platform, integrating dynamic biophysical models and data-driven insights for personalized HCM stratification and improved disease management. Join us in advancing the state of the art in human digital-twins, delivering new insights, enhanced patient care, and a validated strategy through a pilot clinical trial.
TARGET
TARGET project introduces personalised, multi-scale computational models and decision aids for atrial-fibrillation-related stroke. By integrating data from healthy states to disease progression, TARGET aims to revolutionise prevention, acute management and rehabilitation. Patient-centric and backed by industry expertise, the project promises swift adoption of innovative technologies. Through simulation trials, TARGET strives for tangible clinical benefits.
VITAL
VITAL will deliver a comprehensive, clinically validated, multi-scale, multi-organ modelling platform that is driven by and can represent individual patient data acquired both in the clinic and from wearable technology. The platform will create a virtual human twin for individualised and sex-specific optimisation of medical (pharmacological) or surgical (interventional) therapy for complex, multifactorial cardiovascular disorders that have systemic impact and high risk of comorbiditie.
